The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause

Menopause

Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause

Menopause.

Labrie F, Archer DF, Martel C, Vaillancourt M, Montesino M

doi: 10.1097/

Menopause

Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life

Menopause.

Hildreth KL, Ozemek C, Kohrt WM, Blatchford PJ, Moreau KL

Overactive BladderUrinary Incontinence

Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms

Gynecol Endocrinol.

Schiavi MC, Zullo MA, Faiano P, D'Oria O, Prata G, Colagiovanni V, Giannini A, Di Tucci C, Perniola G, Di Donato V, Monti M, Muzii L, Benedetti Panici P

doi: 10.1080/

Menopause

The British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer

Post Reprod Health.

Marsden J, Marsh M, Rigg A; British Menopause Society

doi: 10.1177/2053369118824920.

Erectile and Sexual Functions and DysfunctionsMenopause

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Menopause.

Moral E, Delgado JL, Carmona F, Caballero B, Guillán C, González PM, Suárez-Almarza J, Velasco-Ortega S, Nieto Magro C; writing group of GENISSE study

doi: 10.1097/GME.

Menopause

Onset of the Menopause Transition: The Earliest Signs and Symptoms

Obstet Gynecol Clin North Am.

Gracia CR, Freeman EW

doi: 10.1016/j.ogc.2018.07.002.

Menopause

Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial

JAMA Psychiatry.

Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS

doi: 10.1001/

HPV and Gynecologic Cancer

Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation

Gynecol Oncol.

Hall E, Finch A, Jacobson M, Rosen B, Metcalfe K, Sun P, Narod SA, Kotsopoulos J

doi: 10.1016/j.ygyno.2018.10.040.

Menopause

The Menopause Visual Analogue Scale: a new tool for measuring the severity and response to treatment of symptoms throughout the menopausal transition

Climacteric.

Dama M, Mahoney JL, Van Lieshout RJ, Frey BN, Steiner M

doi: 10.1080/13697137.

Related content

Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause

Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life

Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms

The British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Onset of the Menopause Transition: The Earliest Signs and Symptoms

Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial

Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation

The Menopause Visual Analogue Scale: a new tool for measuring the severity and response to treatment of symptoms throughout the menopausal transition